Michigan voters passed Proposal 2 in the November general election, loosening the restrictions on embryonic stem cell research in the state. Since Dec. 19, Michigan researchers have had the clearance to create new embryonic stem cell lines for disease research from embryos that have been created for fertility treatment purposes.